Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study.
<h4>Objectives</h4>Remdesivir is one of the most widely recommended and used medications for COVID-19 treatment. However, different outcomes have been reported for hospitalized patients with COVID-19 treated with remdesivir. Specifically, the effect of the timing of remdesivir initiation...
Guardado en:
Autores principales: | Hawra Ali Hussain Alsayed, Fatemeh Saheb Sharif-Askari, Narjes Saheb Sharif-Askari, Ali Al Sayed Hussain, Qutayba Hamid, Rabih Halwani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fa8b2f2d4fd54d2fb5c4e080abe02671 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study
por: Hawra Ali Hussain Alsayed, et al.
Publicado: (2021) -
Low Vitamin D Serum Level Is Associated with HDL-C Dyslipidemia and Increased Serum Thrombomodulin Levels of Insulin-Resistant Individuals
por: Saheb Sharif-Askari F, et al.
Publicado: (2020) -
Psychological Distress and Anxiety Levels Among Health Care Workers at the Height of the COVID-19 Pandemic in the United Arab Emirates
por: Basema Saddik, et al.
Publicado: (2021) -
Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality
por: Mdkhana B, et al.
Publicado: (2021) -
Author Correction: Abatacept enhances blood regulatory B cells of rheumatoid arthritis patients to a level that associates with disease remittance
por: Maha Fahad Alenazy, et al.
Publicado: (2021)